DowDuPont Inc. announced three additional members to the future board of directors of DuPont, currently the Specialty Products Division of DowDuPont. The new directors include Frank K. Clyburn, chief commercial officer at Merck & Co. Inc., Terrence R. Curtin, CEO of TE Connectivity, and Frederick M. Lowery, senior vice president and president, Life Sciences Solutions and Laboratory Products at Thermo Fisher Scientific Inc. With these additions, DuPont expects to have 12 members on its board, effective June 1, 2019. In addition to Mr. Clyburn, Mr. Curtin, and Mr. Lowery, DuPont's future board of directors includes: Edward D. Breen, CEO of DowDuPont and executive chairman-elect of DuPont; Ruby R. Chandy, former president of Industrial Division of Pall Corp.; Alexander M. Cutler, lead independent director of DowDuPont and former chairman and chief executive officer of Eaton; Marc Doyle, COO of the Specialty Products Division of DowDuPont and CEO-elect of DuPont; Eleuthère I. du Pont, former president and chief financial officer of Wawa and president of The Longwood Foundation; Rajiv L. Gupta, chairman of APTIV PLC (formerly Delphi Automotive PLC) and former chairman and CEO of Rohm & Haas; Luther C. Kissam, IV, chairman, president and CEO of Albemarle Corporation; Raymond J. Milchovich, former chairman and CEO of Foster Wheeler AG; and Steven Sterin, former executive vice president, CFO of Andeavor and former president of Andeavor Logistics. Frank K. Clyburn is Chief Commercial Officer at Merck. Terrence R. Curtin is the CEO of TE Connectivity. Frederick "Fred" M. Lowery is Senior Vice President and President, Life Sciences Solutions and Laboratory Products at Thermo Fisher Scientific Inc.